Builders FirstSource, Inc. (BLDR)
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Investigation
05/09/2022
Initial Lawsuit
05/19/2022
Lawsuit Progression
07/18/2022
17 C.F.R. § 229.103(a) (Item 103) provides that a company shall disclose “any material pending legal proceedings”, excluding ordinary routine litigation and certain exceptions. On February 16, 2022, Pegasystems disclosed for the first time that its competitor, Appian, had filed a lawsuit alleging “misappropriation of trade secrets” in May 2020, almost two years prior to its disclosure. A jury later awarded Appian more than $2 billion in damages.
We have opened an investor investigation regarding the matter, for which investors are invited to participate, collaborate and track the outcome of the subsequent investors lawsuit filed on May 19, 2022.
05/09/2022
Pegasystems discloses that the jury rendered a verdict “against the Company with respect to the trade secrets claim for $2.04 billion in damages and entitling Appian to recover attorney’s fees” in the matter Appian Corp. v. Pegasystems Inc. & Youyong Zou filed May 29, 2020 in state court in Virginia.
“We strongly disagree with the claims and the verdict, and believe the verdict is not supported by the facts of the case or the law, and is the result of significant error. The Company plans to pursue its post-trial remedies to have the verdict set aside. The Company believes it has meritorious defenses and will vigorously pursue appeal of the trial court’s findings, with the appeals process potentially taking years.”
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$52.25 | $65.93 | $-13.68 | -20.75% |
This is a class action on behalf of all persons and entities that purchased Pegasystems Inc. common stock between May 29, 2020 and May 9, 2022, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(1) Pegasystems had engaged in corporate espionage and misappropriation of trade secrets to better compete against Appian, a principal competitor;
(2) defendants’ product development and associated success was, in significant part, not the result of its own research and product testing but rather the result of such corporate espionage and trade secret theft;
(3) defendants had engaged in a scheme to steal Appian trade secrets, which was not only known to, but carried out through, the personal involvement of the company’s CEO;
(4) the company’s CEO and other officers and employees did not comply with the company’s written Code of Conduct, including its express prohibition on “stealing” confidential information from a competitor and “misrepresenting your identity in hopes of obtaining confidential information”;
(5) the company was “unable to reasonably estimate damages” in the Appian Litigation; and
(6) as a result of the foregoing, defendants’ statements about Pegasystems’ business, operations, prospects, legal compliance, and potential damages exposure in the Appian Litigation were materially false and/or misleading and/or lacked a reasonable basis when made.
The lead plaintiff deadline has passed, we will update this page as the lawsuit progresses.
Last event retrieved on 09/25/2022.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.